Literature DB >> 992867

Lymphocyte and macrophage responses after vaccinia virus infections.

C McLaren, H Cheng, D L Spicer, W A Tompkins.   

Abstract

Using a semimicromethod with washed whole blood, in vitro lymphocyte responses of rabbits to intradermal infection with vaccinia virus was studied. Peritoneal exudate macrophages were infected with vaccinia in vitro to determine the time of appearance of activated macrophages. After primary infection, an increase in spontaneous incorporation of thymidine by blood cultures was found as early as 2 days postinfection. This effect was at a maximum at 7 to 10 days, with counts up to 100-fold higher than before infection. Incubation of these cultures with concanavalin A showed a marked decrease in stimulation index as compared with normals. Although only a transient stimulation with vaccinia was found during the acute infection, stimulation indexes of 2 to 3 were obtained during convalescence. Macrophages from rabbits early after infection supported vaccinia replication, whereas those at day 6 or later resisted infection. Macrophage resistance persisted for 2 to 3 weeks. The response of lymphocytes from rabbits reinfected with vaccinia after 15 weeks differed, with a small increase in spontaneous thymidine uptake, a smaller depression in concanavalin A stimulation, and a greater specific response to vaccinia. Macrophage activation occurred earlier and persisted for a longer time after secondary infection.

Entities:  

Mesh:

Year:  1976        PMID: 992867      PMCID: PMC415487          DOI: 10.1128/iai.14.4.1014-1021.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The role of macrophages in the production of lymphokines by T and B lymphocytes.

Authors:  S M Wahl; J M Wilton; D L Rosenstreich; J J Oppenheim
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  Cellular immune response to viral infection: in vitro studies of lymphocytes from mice infected with Sindbis virus.

Authors:  D E Griffin; R T Johnson
Journal:  Cell Immunol       Date:  1973-12       Impact factor: 4.868

3.  Induction of cellular immunity to herpes simplex virus: relationship to the humoral immune response.

Authors:  G L Rosenberg; A L Notkins
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

4.  Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis viruses.

Authors:  R V Blanden; C A Mims
Journal:  Aust J Exp Biol Med Sci       Date:  1973-06

5.  Stimulation of peripheral blood lymphocytes by herpes simplex virus in vitro.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

6.  Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.

Authors:  R M Schultz; M C Woan; W A Tompkins
Journal:  J Reticuloendothel Soc       Date:  1974-07

7.  Depressed lymphocyte function after measles-mumps-rubella vaccination.

Authors:  T P Munyer; R J Mangi; T Dolan; F S Kantor
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

8.  In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages.

Authors:  W A Tompkins; J M Zarling; W E Rawls
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

9.  In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.

Authors:  G L Rosenberg; P A Farber; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Cell mediated immunity to bovine rhinovirus type 1 in calves.

Authors:  A Hussain; S B Mohanty
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Characteristics of lymphoblasts appearing in efferent lymph in response to immunization with vaccinia virus.

Authors:  T B Issekutz
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

4.  Effect of cell-mediated immune factors on the replication of an attenuated temperature-sensitive mutant of vaccinia virus.

Authors:  F Keller; R Drillien; A Kirn
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Permissiveness of rabbit monocytes and macrophages for herpes simplex virus type 1.

Authors:  S Plaeger-Marshall; L A Wilson; J W Smith
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.

Authors:  A Møller-Larsen; S Haahr
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Attenuation of vaccinia virus by the expression of human Flt3 ligand.

Authors:  Kamila Zurkova; Petr Hainz; Jitka Krystofova; Luda Kutinova; Miloslav Sanda; Sarka Nemeckova
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

9.  Abortive replication of vaccinia virus in activated rabbit macrophages.

Authors:  N A Buchmeier; S R Gee; F A Murphy; W E Rawls
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.